Dunja Dreesens

142 understanding time lags in translational research. J R Soc Med. 2011;104(12):510-20. 23. Green LW, Ottoson JM, Garcia C, Hiatt RA. Diffusion theory and knowledge dissemination, utilization, and integration in public health. Annu Rev Public Health. 2009;30:151-74. 24. Glasziou P, Haynes B. The paths from research to improved health outcomes. Evidence- based nursing. 2005;8(2):36-8. 25. Balas EA, Boren SA. Managing clinical knowledge for health care improvement. Yearbook of Medical Informatics 2000: Patient-Centered Systems. Stuttgart, Germany: Schattauer; 2000. p. 65–70. 26. Sackett DL, Rosenberg WM, Gray JA, Haynes RB, Richardson WS. Evidence based medicine: what it is and what it isn’t. Bmj. 1996;312(7023):71-2. 27. Boyd CM, Darer J, Boult C, Fried LP, Boult L, Wu AW. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: implications for pay for performance. JAMA. 2005;294(6):716-24. 28. Ioannidis JP. Why most published research findings are false. PLoS medicine. 2005;2(8):e124. 29. Haynes RB. Some problems in applying evidence in clinical practice. Ann N Y Acad Sci. 1993;703:210-24; discussion 24-5. 30. Chalmers I, Glasziou P. Avoidable waste in the production and reporting of research evidence. Obstet Gynecol. 2009;114(6):1341-5. 31. Schunemann HJ, Ghersi D, Kreis J, Antes G, Bousquet J. Reporting of Research. In: Gigerenzer G, Muir Gray JA, editors. Better doctors, better patients, better decisions; envisioning health care 2020. Cambridge, Massachusets: The MIT Press; 2011. p. 83-101. 32. Stalmeier PF, van Tol-Geerdink JJ, van Lin EN, Schimmel E, Huizenga H, van Daal WA, et al. Doctors’ and patients’ preferences for participation and treatment in curative prostate cancer radiotherapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2007;25(21):3096-100. 33. Washer P, Joffe H. The “hospital superbug”: social representations of MRSA. Soc Sci Med. 2006;63(8):2141-52. 34. Een visie op richtlijnontwikkeling. Den Haag; 2010. 35. Wennberg JE. Tracking Medicine: A Researcher’s Quest to Understand Health Care. New York: Oxford University Press; 2010. 36. Woolf SH. Practice guidelines: a new reality in medicine. I. Recent developments. Arch Intern Med. 1990;150(9):1811-8. 37. van Everdingen JJE, Dreesens D, Burgers JS, Swinkels JA, Barneveld TA, van der Weijden T. Handboek evidence-based richtlijnontwikkeling: een leidraad voor de praktijk (Manual for evidence-based clinical practice guideline development: guidance for practice). 2nd ed. Houten: Bohn Stafleu van Loghum; 2014. 38. Reese S. Will You Be Pressured to Perform ‘Cookbook’ Medicine? : Medscape; 2013. 39. Goudswaard L, In t Veld K, Dijkstra R. Van richtlijnen, de dingen die niet voorbijgaan (Clinical practice guidelines are here to stay). Huisarst & Wetenschap. 2010;53(1):51-4. 40. Joffe S, Miller FG. Rethinking risk-benefit assessment for phase I cancer trials. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2006;24(19):2987-90. 41. Woolf SH. Practice guidelines, a new reality in medicine. II. Methods of developing guidelines. Arch Intern Med. 1992;152(5):946-52. 42. Grimshaw JM, Thomas RE, MacLennan G, Fraser C, Ramsay CR, Vale L, et al. Effectiveness and efficiency of guideline dissemination and implementation strategies. Health technology assessment. 2004;8(6):iii-iv, 1-72. 43. Gabbay J, le May A. Evidence based guidelines or collectively constructed “mindlines?” Ethnographic study of knowledge management in primary care. Bmj. 2004;329(7473):1013. List of references